Adam Boxer
Clinical trials sponsored by Adam Boxer, explained in plain language.
-
New hope for rare brain disorder: experimental drug enters testing
Disease control Not yet recruitingThis clinical trial is testing whether an experimental drug called LM11A-31 can slow down Progressive Supranuclear Palsy (PSP), a rare and serious brain disorder. The study will involve 147 people with early-stage PSP who can still walk with minimal assistance. Participants will …
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New shot aims to slow devastating brain disease
Disease control Not yet recruitingThis study is testing an investigational drug called AADvac1 to see if it is safe and can slow the progression of Progressive Supranuclear Palsy (PSP), a rare and serious brain disorder. About 146 people with early-stage PSP will be randomly assigned to receive either the active …
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for slowing a rare brain disease
Disease control Not yet recruitingThis is a clinical trial platform designed to test multiple new treatments for Progressive Supranuclear Palsy (PSP), a rare and serious brain disorder. It will start by testing two investigational drugs, AADvac1 and LM11A-31, to see if they are safe and can slow down the worsenin…
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC